Stock 002390 GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Guizhou Xinbang Pharmaceutical Co., Ltd.

Equities

002390

CNE100000NG5

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 27/06/2024 BST 		5-day change 1st Jan Change
3.31 CNY -0.30% Intraday chart for Guizhou Xinbang Pharmaceutical Co., Ltd. -1.49% -25.45%
05-13 Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for the Year 2023, Payable on 17 May 2024 CI
05-09 Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Cash Dividend for 2023 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for the Year 2023, Payable on 17 May 2024
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Cash Dividend for 2023
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.
CI
Xinbang Pharma Chairman Buys 14 Million Yuan More Shares
MT
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. commences an Equity Buyback Plan for 14,705,882 shares, representing 0.76% for CNY 200 million, under the authorization approved on July 13, 2023.
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for the Year 2022, Payable on 30 May 2023
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Final Dividend for 2022
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Proposes Final Dividend for 2022
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Implementation of Final Cash Dividend for 2021, Payable on 24 May 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002390 Stock
  4. News Guizhou Xinbang Pharmaceutical Co., Ltd.
  5. Highlights